Viagra during labor? study tests unusual approach to prevent birth complications
NCT ID NCT06377098
Summary
This pilot study aimed to test whether giving sildenafil citrate (the active ingredient in Viagra) to mothers during labor could reduce fetal distress and birth complications in hospitals with limited resources. Researchers planned to compare sildenafil against a placebo pill in mothers during early labor, tracking both immediate birth outcomes and child development up to three years later. The trial was withdrawn before any participants were enrolled, but was designed to gather information for a larger future study.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAPARTUM FETAL DISTRESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cameroon Baptist Convention Health Services
Douala, Cameroon
-
Egerton University/Nakuru County Referral Hospital
Nakuru, Kenya
-
University Teaching Hospital
Lusaka, Zambia
Conditions
Explore the condition pages connected to this study.